Scarlet Fever Mortality in 2000: U.S. Data & Modern Context

Scarlet fever (scarlatina) is a streptococcal infection (Group A Strep) with characteristic sandpaper rash, strawberry tongue, and high fever. Since the antibiotic era (penicillin), it is rarely fatal with prompt treatment.

2000 U.S. Statistics

• Zero reported deaths from scarlet fever in the United States in 2000 (CDC data).
• Incidence: ~10,000–15,000 cases annually (mostly children 5–15).
• Case-fatality rate: <0.1% with antibiotics.

Historical Contrast

Pre-antibiotics (early 1900s): major killer of children; case-fatality 15–30%. Complications: rheumatic fever (heart damage), post-strep glomerulonephritis, sepsis.

Current Concerns

• Antibiotic resistance (macrolide resistance in GAS rising)
• Re-emergence of invasive GAS (iGAS) and toxic shock
• Diagnostic delays in underserved populations

Scarlet fever remains a notifiable disease in many jurisdictions. Treatment: penicillin/amoxicillin 10 days (or single-dose benzathine penicillin IM). Contacts: test/treat if symptomatic.